Kleykamp, B. A., Dworkin, R. H., Turk, D. C., Bhagwagar, Z., Cowan, P., Eccleston, C., Ellenberg, S. S., Evans, S. R., Farrar, J. T., Freeman, R. L., Garrison, L. P., Gewandter, J. S., Goli, V., Iyengar, S., Jadad, A. R., Jensen, M. P., Junor, R., Katz, N. P., Kesslak, J. P., Kopecky, E. A., Lissin, D., Markman, J. D., McDermott, M. P., Mease, P. J., O'Connor, A. B., Patel, K. V., Raja, S. N., Rowbotham, M. C., Sampaio, C., Singh, J. A., Steigerwald, I., Strand, V., Tive, L. A., Tobias, J., Wasan, A. D., & Wilson, H. D. (2022). benefit–risk assessment and reporting in clinical trials of chronic pain treatments: IMMPACT recommendations. Pain, 163(6), 1006–1018. http://access.bl.uk/ark:/81055/vdc_100155027482.0x000032